Microbiologists and chemists at the University of South Florida have developed and patented a synthetic compound that has shown antibiotic action against methicillin resistant Staphylococcus aureus, also known as MRSA, which ...
Jan 29, 2015
0
29
Last month WHO issued a report that warned of an increase of antimicrobial-resistance and the renewed threat of bacterial infections world-wide and called for a concerted effort to develop new and better antimicrobial drugs. ...
May 22, 2014
0
1
An estimated 30,800 fewer invasive methicillin-resistant Staphylococcus aureus (MRSA) infections occurred in the United States in 2011 compared to 2005, according to a study in JAMA Internal Medicine by Raymund Dantes, M.D., ...
Sep 16, 2013
0
0
Staph infections in hospitals are a serious concern, so much so that the term Methicillin-resistant Staphylococcus aureus (MRSA) is as commonly known as MRI. Far less known is that in many of these cases, patients are infecting ...
Jun 13, 2013
0
0
A policy of regularly washing every patient in the intensive care unit with antimicrobial cloths helped cut down on dangerous blood infections by 44 percent, a US study said Wednesday.
May 29, 2013
0
0
(HealthDay)—A daily swabbing with a simple antiseptic greatly decreases the number of life-threatening bloodstream infections and drug-resistant bacteria lurking among patients in acute-care hospital units, a new study ...
Feb 6, 2013
0
0
In 2002, a new kind of bacterial infection was detected in the United States. It was caused by a common bug, Staphylococcus aureus, but with a troubling new twist. It was resistant to the drug that typically offered the last ...
Jan 2, 2013
0
0
Investigators at the Center for Structural Genomics of Infectious Diseases (CSGID) and the Seattle Structural Genomics Center for Infectious Disease (SSGCID) announced today that they reached a significant milestone by determining ...
Jun 5, 2012
0
0
(HealthDay) -- Phylogenomic analysis has revealed details about the emergence and transmission of a major methicillin-resistant Staphylococcus aureus (MRSA) clone, EMRSA-16, according to research published online May 14 in ...
May 21, 2012
0
0
(Medical Xpress) -- In the hospital environment where antibiotic usage is extremely high, it seems that healthcare associated methicillin resistant Staphylococcus aureus (MRSA) has cleverly adapted for survival.
Apr 25, 2012
0
0
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for several difficult-to-treat infections in humans. It is also called multidrug-resistant Staphylococcus aureus and oxacillin-resistant Staphylococcus aureus (ORSA). MRSA is any strain of Staphylococcus aureus that has evolved resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. The development of such resistance does not cause the organism to be more intrinsically virulent than strains of Staphylococcus aureus that have no antibiotic resistance, but resistance does make MRSA infection more difficult to treat with standard types of antibiotics and thus more dangerous.
MRSA is especially troublesome in hospitals and nursing homes, where patients with open wounds, invasive devices, and weakened immune systems are at greater risk of infection than the general public.
This text uses material from Wikipedia licensed under CC BY-SA
